Rachel K. Miller

Statistics

Publications

Citations

3.2K

H-Index

Active since

1993

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Emory University

University of Oxford

Rachel K. Miller is an author at The University of Texas MD Anderson Cancer Center specializing in life sciences, cell biology, and molecular biology.

ORCID

Publications per year

1993–2024

Publications

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

Lung epithelial branching program antagonizes alveolar differentiation

Daniel R. Chang, Denise Martinez Alanis, Rachel K. Miller et al. · Proceedings of the National Academy of Sciences · 2013 · 192 citations · Full text

Life Sciences, Developmental Biology, Physiology +14

1–5 of 33